|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Elevation Oncology (NASDAQ: ELEV) through any online brokerage.
The latest price target for Elevation Oncology (NASDAQ: ELEV) was reported by Wedbush on July 20, 2021. The analyst firm set a price target for 27.00 expecting ELEV to rise to within 12 months (a possible 237.50% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $8 last updated Today at 4:06:48 PM.
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.